Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Health Catalyst’s Role in Healthcare Analytics in APAC

The future of the healthcare industry is increasingly being shaped by data and analytics. That’s why, for this episode of Owning the Future of Healthcare by Health Catalyst, host Daniel Litwin was joined by Farhana Nakhooda, Health Catalyst Senior Vice President of Healthcare and Life Sciences for APAC, who shared her influential insights. In particular,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Health Catalyst’s Role in Healthcare Analytics in APAC

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The future of the healthcare industry is increasingly being shaped by data and analytics. That’s why, for this episode of Owning the Future of Healthcare by Health Catalyst, host Daniel Litwin was joined by Farhana Nakhooda, Health Catalyst Senior Vice President of Healthcare and Life Sciences for APAC, who shared her influential insights.

In particular, Nakhooda contributed to an in-depth discussion about the organization’s impact on the efficient and equitable use of data and analytics in the Asia-Pacific region, or APAC.

Because the region is so large, Nakhooda said it’s impossible to generalize about universal trends in the area. However, when viewed through the lens of developed and developing markets, some easier-to-identify groupings and trends emerge.

While developed markets are more prepared for analytics than their developing counterparts thanks to, in many cases, years of EMR use, that doesn’t mean the adoption of more robust analytics will be simple. For example, digitization varies greatly among even developed markets, which can lead to implementation challenges.

Among developing markets, work is still centralized around enabling data capture in the first place.

Even though these segments of the region are at different stages of preparedness and adoption, Nakhooda said they do have some things in common, such as a requirement to share data with their governments.

Health Catalyst is working to help the region increase understanding of data security and the structure around data sharing and governance, as well as to help increase data and analytics literacy in the region, which is shining a spotlight on the power of data in improving outcomes and more.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512